Skip to main content
TECNOVAX S.A. logo

TECNOVAX S.A. — Investor Relations & Filings

ISIN · ARTNVX560020 BYMA Manufacturing
Open in API
Filings indexed 121 across all filing types
Latest filing 2024-05-15 Capital/Financing Update
Country AR Argentina
Listing BYMA

About TECNOVAX S.A.

https://tecnovax.com/en/home-eng/

TECNOVAX S.A. is a biotechnology company dedicated to animal health, specializing in the research, development, and production of vaccines and immunotherapies. Leveraging its scientific expertise and decades of research, the company delivers safe and effective biological products for disease prevention. Its product portfolio targets a wide range of animals, including livestock such as ruminants and equines, aquatic species like salmonids, and companion animals including dogs and cats.

Recent filings

Filing Released Lang Actions
FECHA: 15-05-2024 - - ART. 10 LON
Capital/Financing Update Classification · 95% confidence The document is titled 'AVISO DE EMISIÓN' (Notice of Issuance) and details the issuance of additional negotiable obligations (debt instruments) by TECNOVAX S.A. It references specific approval dates, terms of the issuance, interest rates, maturity dates, and amounts. The content focuses on the announcement of new debt issuance under an existing program, including legal and financial details relevant to the issuance. There are no financial statements, quarterly or annual results, or management discussion of financial performance. The document is a formal announcement of a capital raising event through debt issuance. Therefore, it fits best under 'Capital/Financing Update' (CAP). The document length (9192 characters) supports it being a full announcement rather than a brief notice or a report publication announcement.
2024-05-15 Spanish
FEC. CELEB.: 15-05-2024 - TEMA: EMISIONES DE INSTRUMENTOS (ACCIONES - ON - VCP - FF) - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the terms and conditions of additional negotiable obligations (debt securities) issued by Tecnovax S.A. It includes specifics about the issuance, interest rates, maturity, listing, and regulatory compliance related to these debt instruments. The text references a Supplement to the Prospectus and details about the offering and negotiation, indicating it is a capital raising or financing activity. There is no indication that this is a full annual or interim financial report, audit report, or earnings release. It is not a regulatory filing or announcement of voting results, nor is it related to management changes or legal proceedings. The document is clearly an update on the company's capital structure and financing activities through the issuance of additional debt securities under a program. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2024-05-15 Spanish
FECHA PUBLIC.: 15-05-2024 - INSTRUMENTO: PYMENEGOTIABLEOBLIGATION - - PROGRAMA: PROGRAMA GLOBAL DE EMISIÓN DE OBLIGACIONES NEGOCIABLES SIMPLES (NO CONVERTIBLES EN ACCIONES) BAJO EL - SERIE :ONS PYME S
Capital/Financing Update Classification · 100% confidence The document is titled 'Suplemento de Prospecto' and details additional issuance of negotiable obligations (debt securities) by Tecnovax S.A. It discusses terms, conditions, issuance amounts, interest rates, regulatory approvals, and listing intentions. The text references a prospectus and supplements it, indicating it is a supplement to a debt offering prospectus. It includes detailed information about the securities issuance program, regulatory compliance, and investor qualifications. This is characteristic of a Capital/Financing Update, specifically related to bond issuance and financing activities. It is not an annual report, earnings release, or other financial report. It is not a simple announcement of a report but a detailed supplement to a prospectus for a financing program. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2024-05-15 Spanish
FEC. CELEB.: 13-05-2024 - TEMA: EECC - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Board/Management Information Classification · 95% confidence The document is a meeting minute ('Acta de Directorio') of the Board of Directors of Tecnovax S.A. dated May 13, 2024. The main agenda item is the approval of the financial statements for the nine-month period ended March 31, 2024. The document records the approval of the financial statements by the board and authorization for the president to sign them. It is not the financial statements themselves but a record of the board meeting approving them. This fits the category of Board/Management Information (MANG), which includes announcements of board decisions and approvals. The document length is short (1928 characters), and it is not a full financial report or audit report. Therefore, the correct classification is MANG with high confidence.
2024-05-13 Spanish
NORMA CONTABLE: NCP - TIPO BALANCE: INDIVIDUAL - PERIODICIDAD: TRIMESTRAL - FECHA CIERRE: 2024-03-31 - ESTADOS CONTABLES - PYMES CNV, ADC, ACRYP Y CC
Regulatory Filings
2024-05-13 Spanish
FECHA: 09-05-2024 - - ART. 10 LON
Regulatory Filings
2024-05-09 Spanish

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.